Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

ACHCAcadia Healthcare Company, Inc.

Nasdaq · CIK 0001520697
Filer categoryLarge accelerated filer
Entity typeoperating
SIC8093 Services-Specialty Outpatient Facilities, NEC
FY end1231
XBRL facts532

Identity from submissions API

NameAcadia Healthcare Company, Inc.
CIK0001520697
TickersACHC
ExchangesNasdaq
Entity typeoperating
CategoryLarge accelerated filer
SIC8093 Services-Specialty Outpatient Facilities, NEC
EIN000000000
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone615-861-6000
Website—
Investor website—
Owner org08 Industrial Applications and Services
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
6100 TOWER CIRCLE
SUITE 1000
FRANKLIN
TN
37067
TN
Mailing address
6100 TOWER CIRCLE
SUITE 1000
FRANKLIN
TN
37067
TN

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

No Financialist filing articles yet for this CIK.

SEC filings

1308 filing rows loaded from submissions recent; extra archives: CIK0001520697-submissions-001.json (308 filings, 2011-05-24 to 2014-01-27).

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000902219-26-000351 005-86704 261557829 34 15534
2026-11-04 10-Q 10-Q 0001193125-26-447412 001-35331 261523008 34 11744902 1 1
2026-11-04 8-K FORM 8-K 2.02,7.01,9.01 0001437749-26-034941 001-35331 261522279 34 2887468 1 1
2026-10-08 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000354204-26-001066 005-86704 261449578 34 8711
2026-09-25 8-K FORM 8-K 8.01,9.01 0001437749-26-031225 001-35331 261410524 34 755124 1 1
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-003445 005-86704 261275930 34 12316
2026-08-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000902219-26-000250 005-86704 261273329 34 17396
2026-08-06 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-001929 005-86704 261246901 34 11666
2026-07-28 8-K FORM 8-K 2.02,7.01,9.01 0001437749-26-024693 001-35331 261212761 34 3167027 1 1
2026-07-28 10-Q 10-Q 0001193125-26-321076 001-35331 261212292 34 11582469 1 1
2026-07-27 4 4 0001193125-26-318240 4538
2026-07-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-002158 005-86704 261206023 34 11107
2026-06-26 4 4 0001193125-26-285667 4538
2026-05-18 8-K 8-K 8.01 0001193125-26-229138 001-35331 26994904 34 139833 1 1
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-002398 005-86704 26989659 34 12255
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000902219-26-000147 005-86704 26982221 34 17369
2026-05-11 S-8 S-8 0001193125-26-217120 333-295773 26964486 33 211805 1 1
2026-05-11 3 3 0001193125-26-217089 15548
2026-05-11 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000886982-26-000164 005-86704 26962065 34 18379
2026-05-08 4 4 0001193125-26-215070 4683
2026-05-08 4 4 0001193125-26-214932 4752
2026-05-08 4 4 0001193125-26-214931 4714
2026-05-08 4 4 0001193125-26-214930 6273
2026-05-08 4 4 0001193125-26-214929 4714
2026-05-08 4 4 0001193125-26-214927 4712
2026-05-08 4 4 0001193125-26-214926 4690
2026-05-08 4 4 0001193125-26-214925 8497
2026-05-08 4 4 0001193125-26-214924 6306
2026-05-06 4 4 0001193125-26-209423 4537
2026-05-06 8-K 8-K 5.07,9.01 0001193125-26-209324 001-35331 26949539 34 156779 1 1
2026-04-30 4 4 0001193125-26-198070 4740
2026-04-30 10-Q 10-Q 0001193125-26-192508 001-35331 26918514 34 10061320 1 1
2026-04-29 8-K FORM 8-K 2.02,7.01,9.01 0001437749-26-013916 001-35331 26918155 34 2362236 1 1
2026-04-29 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002100119-26-000123 005-86704 26916967 34 7452
2026-04-28 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002100121-26-000063 005-86704 26907273 34 7396
2026-04-23 8-K 8-K 5.02,7.01,9.01 0001193125-26-173769 001-35331 26888955 34 320836 1 1
2026-04-13 4 4 0001193125-26-153040 4812
2026-04-13 4 4 0001193125-26-153039 4738
2026-03-26 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-000501 005-86704 26797267 34 7218
2026-03-25 ARS ARS 0001140361-26-011134 001-35331 26793372 34 2797808
2026-03-25 DEFA14A DEFA14A 0001140361-26-011132 001-35331 26793363 34 1282318
2026-03-25 DEF 14A DEF 14A 0001140361-26-011130 001-35331 26793342 34 9082676 1 1
2026-03-18 4 4 0001193125-26-114519 4675
2026-03-18 3 3 0001193125-26-114513 16413
2026-03-12 8-K 8-K 5.02,7.01,9.01 0001193125-26-104272 001-35331 26748296 34 181633 1 1
2026-03-11 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001539497-26-000915 005-86704 26745471 34 12723
2026-02-27 4 4 0001193125-26-083110 4397
2026-02-27 10-K 10-K 0001193125-26-078266 001-35331 26691675 34 17864403 1 1
2026-02-25 8-K FORM 8-K 2.02,7.01,9.01 0001437749-26-005431 001-35331 26674194 34 4325554 1 1
2026-02-12 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000886982-26-000056 005-86704 26623907 34 18202
2026-02-10 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902219-26-000089 005-86704 26614332 34 17272
2026-01-23 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001539497-26-000135 005-86704 26554845 34 29779
2026-01-23 8-K 8-K 5.02,9.01 0001193125-26-020169 001-35331 26553358 34 233489 1 1
2026-01-21 4 4 0001193125-26-018061 5965
2026-01-21 3 3 0001193125-26-018043 16326
2026-01-20 8-K FORM 8-K 5.02,7.01,9.01 0001437749-26-001486 001-35331 26541170 34 458005 1 1
2026-01-13 8-K FORM 8-K 2.02,7.01,9.01 0001437749-26-001137 001-35331 26528473 34 2021266 1 1
2025-12-02 8-K FORM 8-K 7.01,9.01 0001437749-25-036657 001-35331 251543256 34 210627 1 1
2025-11-24 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001539497-25-003053 005-86704 251514686 34 64165
2025-11-10 8-K 8-K 7.01,9.01 0001193125-25-274380 001-35331 251466724 34 143942 1 1
2025-11-05 10-Q 10-Q 0001193125-25-267062 001-35331 251454548 34 12154977 1 1
2025-11-05 8-K FORM 8-K 2.02,5.02,9.01 0001437749-25-033347 001-35331 251454070 34 813000 1 1
2025-10-28 4 4 0001193125-25-253974 4676
2025-10-28 3 3 0001193125-25-253947 15253
2025-10-07 8-K 8-K 5.02,7.01,9.01 0001193125-25-233507 001-35331 251380085 34 321063 1 1
2025-10-06 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000102909-25-000015 005-86704 251377661 34 6261
2025-10-06 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902219-25-000363 005-86704 251376189 34 17252
2025-10-02 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002012383-25-001647 005-86704 251371443 34 11045
2025-10-01 4 4 0001193125-25-226935 4409
2025-10-01 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0001539497-25-002580 005-86704 251364571 34 162294
2025-09-29 8-K 8-K 7.01 0001193125-25-221545 001-35331 251352084 34 142820 1 1
2025-08-25 3 3 0001193125-25-187817 20188
2025-08-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902219-25-000278 005-86704 251204922 34 17248
2025-08-05 10-Q 10-Q 0000950170-25-103160 001-35331 251185701 34 11195215 1 1
2025-08-05 8-K FORM 8-K 2.02,5.02,9.01 0001437749-25-024875 001-35331 251185523 34 741112 1 1
2025-07-29 4 4 0000950170-25-099722 4452
2025-07-29 4 4 0000950170-25-099721 4394
2025-06-27 4 4 0000950170-25-091002 4430
2025-06-27 4 4 0000950170-25-091001 4452
2025-06-27 4 4 0000950170-25-091000 4393
2025-05-30 4 4 0000950170-25-079852 4603
2025-05-30 4 4 0000950170-25-079851 4545
2025-05-30 4 4 0000950170-25-079850 4573
2025-05-30 4 4 0000950170-25-079848 8355
2025-05-30 4 4 0000950170-25-079849 6144
2025-05-30 4 4 0000950170-25-079847 4542
2025-05-30 4 4 0000950170-25-079845 6130
2025-05-30 4 4 0000950170-25-079846 6169
2025-05-30 4 4 0000950170-25-079844 4549
2025-05-30 S-8 S-8 0001140361-25-020960 333-287698 251011990 33 292178 1 1
2025-05-30 8-K 8-K 5.07,9.01 0001193125-25-132208 001-35331 251011476 34 160489 1 1
2025-05-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001897612-25-000201 005-86704 25943484 34 7690
2025-05-13 4 4 0000950170-25-070507 4429
2025-05-12 8-K FORM 8-K 2.02,9.01 0001437749-25-016141 001-35331 25935502 34 563317 1 1
2025-05-12 10-Q 10-Q 0000950170-25-069294 001-35331 25935356 34 9893231 1 1
2025-05-07 4 4 0000950170-25-066062 4651
2025-05-07 4 4 0000950170-25-066037 4593
2025-05-07 4 4 0000950170-25-066035 4609
2025-05-07 4 4 0000950170-25-066028 6107
2025-04-11 4 4 0000950170-25-053363 4429
2025-04-10 ARS ARS 0001140361-25-013296 001-35331 25829133 34 2331702
2025-04-10 DEFA14A DEFA14A 0001140361-25-013295 001-35331 25829126 34 300863
2025-04-10 DEF 14A DEF 14A 0001140361-25-013294 001-35331 25829110 34 3500113 1 1
2025-03-10 8-K 8-K 1.01,2.03,8.01,9.01 0001193125-25-051083 001-35331 25724788 34 1340803 1 1
2025-03-03 4 4 0000950170-25-030983 4415
2025-02-28 4 4 0000950170-25-030198 4790
2025-02-28 4 4 0000950170-25-030197 4732
2025-02-28 4 4 0000950170-25-030196 7681
2025-02-28 8-K 8-K 1.01,1.02,2.03,9.01 0001193125-25-042573 001-35331 25691068 34 1425221 1 1
2025-02-27 10-K 10-K 0000950170-25-029095 001-35331 25679359 34 16492388 1 1
2025-02-27 8-K FORM 8-K 2.02,9.01 0001437749-25-005467 001-35331 25678843 34 736636 1 1
2025-02-20 UPLOAD filename1.pdf 0000000000-25-001991 001-35331 39826
2025-02-18 CORRESP filename1.htm 0001193125-25-028713 130441
2025-02-12 UPLOAD filename1.pdf 0000000000-25-001611 001-35331 43443
2025-02-12 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-25-000698 005-86704 25612288 34 11538
2025-01-21 CORRESP filename1.htm 0001193125-25-009700 158693
2025-01-13 8-K 8-K 2.02 0001193125-25-005003 001-35331 25524883 34 143571 1 1
2024-12-23 CORRESP filename1.htm 0001193125-24-284312 32136
2024-12-20 UPLOAD filename1.pdf 0000000000-24-014133 001-35331 44422
2024-12-06 CORRESP filename1.htm 0001193125-24-272397 182836
2024-11-25 CORRESP filename1.htm 0001193125-24-265343 31792
2024-11-15 UPLOAD filename1.pdf 0000000000-24-012669 001-35331 45926
2024-11-14 SC 13G/A achc13gasep24.txt 0001897612-24-001935 005-86704 34 6565
2024-11-12 SC 13G/A filing.txt 0000315066-24-002664 005-86704 241444450 34 8406
2024-11-08 4 4 0000950170-24-124222 5782
2024-11-08 SC 13G/A SEC SCHEDULE 13G 0000902219-24-000459 005-86704 241438668 34 36203
2024-10-30 8-K FORM 8-K 2.02,9.01 0001437749-24-032658 001-35331 241411536 34 679697 1 1
2024-10-30 10-Q 10-Q 0000950170-24-119044 001-35331 241410826 34 9399729 1 1
2024-09-27 8-K 8-K 8.01 0001193125-24-227393 001-35331 241330632 34 146561 1 1
2024-08-30 144 xsl144X01/primary_doc.xml 0002002698-24-000349 001-35331 241270421 33 4874
2024-08-29 144 xsl144X01/primary_doc.xml 0002002698-24-000330 001-35331 241263676 33 4288
2024-08-08 144 xsl144X01/primary_doc.xml 0002007317-24-000533 001-35331 241188074 33 4277
2024-08-01 10-Q 10-Q 0000950170-24-089248 001-35331 241166547 34 9129421 1 1
2024-07-31 8-K FORM 8-K 2.02,9.01 0001437749-24-024148 001-35331 241163082 34 621456 1 1
2024-07-29 4 4 0000950170-24-087347 4458
2024-07-29 4 4 0000950170-24-087346 4401
2024-07-01 3 3 0000950170-24-079729 14686
2024-06-28 4 4 0000950170-24-079132 4663
2024-06-28 4 4 0000950170-24-079131 4607
2024-06-28 4 4 0000950170-24-079130 4642
2024-06-06 SC 13G/A SEC SCHEDULE 13G 0000902219-24-000308 005-86704 241024072 34 37907
2024-05-31 4 4 0000950170-24-067344 12758
2024-05-28 4 4 0000950170-24-065516 4556
2024-05-28 4 4 0000950170-24-065514 14066
2024-05-28 4 4 0000950170-24-065512 12494
2024-05-28 4 4 0000950170-24-065511 12712
2024-05-28 4 4 0000950170-24-065506 12744
2024-05-28 4 4 0000950170-24-065503 4555
2024-05-28 4 4 0000950170-24-065502 8364
2024-05-28 4 4 0000950170-24-065499 4553
2024-05-24 8-K 8-K 5.02,5.03,5.07,9.01 0001193125-24-146576 001-35331 24981141 34 495198 1 1
2024-05-10 4 4 0000950170-24-057973 4437
2024-05-10 4 4 0000950170-24-057972 4435
2024-05-02 10-Q 10-Q 0000950170-24-052085 001-35331 24908141 34 8365981 1 1
2024-05-01 8-K FORM 8-K 2.02,9.01 0001437749-24-014205 001-35331 24904052 34 500982 1 1
2024-04-24 4 4 0000950170-24-047693 4437
2024-04-15 4 4 0000950170-24-044485 4437
2024-04-15 4 4 0000950170-24-044484 4435
2024-04-09 ARS ARS 0001140361-24-018897 001-35331 24833473 34 2256617
2024-04-09 DEFA14A DEFA14A 0001140361-24-018896 001-35331 24833460 34 982277
2024-04-09 DEF 14A DEF 14A 0001140361-24-018895 001-35331 24833433 34 6872401 1 1
2024-03-28 PRE 14A PRE 14A 0001140361-24-016223 001-35331 24800164 34 6886861 1 1
2024-03-26 4 4 0000950170-24-036540 4438
2024-03-08 144 xsl144X01/primary_doc.xml 0001974078-24-000107 001-35331 24734014 33 4427
2024-03-06 4 4 0000950170-24-027357 15519
2024-03-06 4 4 0000950170-24-027348 14456
2024-03-04 144 xsl144X01/primary_doc.xml 0002007317-24-000272 001-35331 24716055 33 5293
2024-03-01 4 4 0000950170-24-024132 4793
2024-03-01 4 4 0000950170-24-024130 4736
2024-03-01 4 4 0000950170-24-024126 9359
2024-03-01 4 4 0000950170-24-024124 6439
2024-03-01 4/A 4/A 0000950170-24-024116 16359
2024-02-28 10-K 10-K 0000950170-24-022057 001-35331 24695218 34 16162478 1 1
2024-02-27 8-K FORM 8-K 2.02,9.01 0001437749-24-005735 001-35331 24688577 34 694640 1 1
2024-02-14 SC 13G/A achc13gadec23.txt 0001897612-24-001215 005-86704 34 6574
2024-02-13 SC 13G/A SCHEDULE 13G/A 0001104659-24-020161 005-86704 24627183 34 13109
2024-02-09 SC 13G/A SEC SCHEDULE 13G 0000354204-24-002919 005-86704 24612148 34 19519
2024-02-09 SC 13G filing.txt 0000315066-24-000958 005-86704 24611345 34 8196
2024-02-08 SC 13G/A SEC SCHEDULE 13G 0000902219-24-000037 005-86704 24607229 34 37738
2024-01-25 SC 13G/A us00404a1097_012524.txt 0001086364-24-003317 005-86704 24561082 34 13747
2024-01-19 8-K 8-K 1.01,2.03,9.01 0001193125-24-011225 001-35331 24545537 34 1552848 1 1
2023-12-14 4 4 0000950170-23-070551 6760
2023-11-16 4 4 0000950170-23-064559 11493
2023-11-15 144 xsl144X01/primary_doc.xml 0001971857-23-000860 001-35331 231409741 33 6552
2023-11-14 144 xsl144X01/primary_doc.xml 0001971857-23-000855 001-35331 231407905 33 5946
2023-11-13 4 4 0000950170-23-063176 7358
2023-11-13 4 4 0000950170-23-063169 5704
2023-11-13 4 4 0000950170-23-063149 15631
2023-11-13 144/A xsl144X01/primary_doc.xml 0001971857-23-000837 001-35331 231399984 33 5503
2023-11-13 144/A xsl144X01/primary_doc.xml 0001971857-23-000835 001-35331 231399770 33 4897
2023-11-13 144 xsl144X01/primary_doc.xml 0001971857-23-000822 001-35331 231396109 33 5337
2023-11-08 144 xsl144X01/primary_doc.xml 0001971857-23-000816 001-35331 231389504 33 4733
2023-11-03 10-Q 10-Q 0000950170-23-058814 001-35331 231376324 34 11046400 1 1
2023-11-02 8-K ACADIA HEALTHCARE COMPANY, INC. 8-K 2.02,9.01 0001157523-23-001637 001-35331 231373673 34 780399 1 1
2023-10-30 8-K 8-K 1.01,9.01 0001193125-23-266248 001-35331 231361002 34 363738 1 1
2023-10-27 4 4 0000950170-23-056055 4488
2023-10-27 3 3 0000950170-23-056050 11968
2023-10-26 8-K 8-K 5.02,9.01 0001193125-23-264094 001-35331 231350368 34 170436 1 1
2023-10-11 8-K 8-K 8.01 0001193125-23-254205 001-35331 231321294 34 149342 1 1
2023-08-15 4 4 0000950170-23-042862 13264
2023-07-28 10-Q 10-Q 0000950170-23-035484 001-35331 231123050 34 11995950 1 1
2023-07-27 4 4 0000950170-23-035225 4598
2023-07-27 4 4 0000950170-23-035220 4533
2023-07-27 3 3 0000950170-23-035215 12818
2023-07-27 8-K ACADIA HEALTHCARE COMPANY, INC. 8-K 2.02,9.01 0001157523-23-001176 001-35331 231118515 34 695757 1 1
2023-07-11 3 3 0000950170-23-032532 13564
2023-07-11 8-K ACADIA HEALTHCARE COMPANY, INC. 8-K 8.01 0001157523-23-001076 001-35331 231082225 34 160664 1 1
2023-07-05 8-K 8-K 5.02,9.01 0001193125-23-182040 001-35331 231070567 34 380104 1 1
2023-06-02 8-K 8-K 5.02,9.01 0001193125-23-159929 001-35331 23989923 34 341056 1 1
2023-05-19 4 FORM 4 SUBMISSION 0000899243-23-013389 4744
2023-05-19 4 FORM 4 SUBMISSION 0000899243-23-013388 4707
2023-05-19 4 FORM 4 SUBMISSION 0000899243-23-013385 6457
2023-05-19 4 FORM 4 SUBMISSION 0000899243-23-013387 4714
2023-05-19 4 FORM 4 SUBMISSION 0000899243-23-013391 4686
2023-05-19 4 FORM 4 SUBMISSION 0000899243-23-013390 4673
2023-05-19 4 FORM 4 SUBMISSION 0000899243-23-013386 4688
2023-05-19 4 FORM 4 SUBMISSION 0000899243-23-013384 4692
2023-05-19 4 FORM 4 SUBMISSION 0000899243-23-013383 8418
2023-05-19 8-K 8-K 5.02,5.07,9.01 0001193125-23-149461 001-35331 23941274 34 159913 1 1
2023-05-11 4 4 0000950170-23-021424 5689
2023-05-11 4 4 0000950170-23-021422 4542
2023-05-11 4 4 0000950170-23-021423 4544
2023-05-11 4 4 0000950170-23-021421 4590
2023-05-11 4 4 0000950170-23-021419 4548
2023-05-04 4 4 0000950170-23-017959 4211
2023-05-04 4 4 0000950170-23-017957 5383
2023-04-27 10-Q 10-Q 0000950170-23-015296 001-35331 23857265 34 13052526 1 1
2023-04-26 8-K ACADIA HEALTHCARE COMPANY, INC. 8-K 2.02,9.01 0001157523-23-000620 001-35331 23849818 34 522743 1 1
2023-04-25 4 FORM 4 SUBMISSION 0000899243-23-011668 4589
2023-04-25 4 FORM 4 SUBMISSION 0000899243-23-011666 4605
2023-04-25 4 FORM 4 SUBMISSION 0000899243-23-011665 4598
2023-04-25 4 4 0000950170-23-014516 5519
2023-04-13 4 4 0000950170-23-012739 4341
2023-04-13 4 4 0000950170-23-012738 4332
2023-04-13 4 4 0000950170-23-012736 4348
2023-04-07 ARS ARS 0001140361-23-017326 001-35331 23808802 34 1608981
2023-04-07 DEFA14A DEFA14A 0001140361-23-017324 001-35331 23808796 34 671375
2023-04-07 DEF 14A DEF 14A 0001140361-23-017321 001-35331 23808781 34 5867818 1 1
2023-03-27 4 FORM 4 SUBMISSION 0000899243-23-009735 4590
2023-03-27 4 FORM 4 SUBMISSION 0000899243-23-009734 4599
2023-03-27 4 FORM 4 SUBMISSION 0000899243-23-009733 4606
2023-03-27 4 FORM 4 SUBMISSION 0000899243-23-009732 5749
2023-03-09 4 FORM 4 SUBMISSION 0000899243-23-007761 4567
2023-02-28 10-K 10-K 0001564590-23-002737 001-35331 23685463 34 19670981 1 1
2023-02-27 8-K ACADIA HEALTHCARE COMPANY, INC. 8-K 2.02,9.01 0001157523-23-000366 001-35331 23674904 34 797087 1 1
2023-02-23 4 FORM 4 SUBMISSION 0000899243-23-006023 6200
2023-02-23 4 FORM 4 SUBMISSION 0000899243-23-006018 4873
2023-02-23 4 FORM 4 SUBMISSION 0000899243-23-006017 9252
2023-02-23 4 FORM 4 SUBMISSION 0000899243-23-006016 8114
2023-02-23 4 FORM 4 SUBMISSION 0000899243-23-006015 8098
2023-02-23 4 FORM 4 SUBMISSION 0000899243-23-006011 8107
2023-02-14 5 FORM 5 SUBMISSION 0000899243-23-004998 7073
2023-02-14 SC 13G/A achc13gadec22.txt 0001897612-23-000706 005-86704 34 9842
2023-02-10 SC 13G/A SEC SCHEDULE 13G 0000354204-23-001336 005-86704 23610709 34 19413
2023-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-23-015188 005-86704 23602143 34 13007
2023-02-06 SC 13G/A SEC SCHEDULE 13G 0000846087-23-000064 005-86704 23590021 34 37347
2023-01-25 SC 13G us00404a1097_012523.txt 0001306550-23-003499 005-86704 23550532 34 13458
2022-12-07 8-K ACADIA HEALTHCARE COMPANY, INC. 8-K 7.01,9.01 0001157523-22-001710 001-35331 221449188 34 177975 1 1
2022-11-02 10-Q 10-Q 0001564590-22-036269 001-35331 221353292 34 12711240 1 1
2022-11-01 8-K/A ACADIA HEALTHCARE COMPANY, INC. 8-K/A 2.02,7.01,9.01 0001157523-22-001454 001-35331 221348495 34 854347 1 1
2022-10-31 8-K ACADIA HEALTHCARE COMPANY, INC. 8-K 2.02,9.01 0001157523-22-001443 001-35331 221346728 34 850630 1 1
2022-09-09 4 FORM 4 SUBMISSION 0000899243-22-030739 5063
2022-08-16 4 FORM 4 SUBMISSION 0000899243-22-028819 4567
2022-08-16 4 FORM 4 SUBMISSION 0000899243-22-028818 4558
2022-08-10 SC 13G achc13gjul22.txt 0001897612-22-000263 005-86704 34 9550
2022-08-10 SC 13G/A achc13gajul22.txt 0000080255-22-002496 005-86704 34 9706
2022-08-08 4 FORM 4 SUBMISSION 0000899243-22-028021 5122
2022-08-08 4 FORM 4 SUBMISSION 0000899243-22-028020 6653
2022-08-08 4 FORM 4 SUBMISSION 0000899243-22-028018 12099
2022-08-02 4 FORM 4 SUBMISSION 0000899243-22-027403 5055
2022-07-28 10-Q 10-Q 0001564590-22-026910 001-35331 221115857 34 12613345 1 1
2022-07-27 8-K ACADIA HEALTHCARE COMPANY, INC. 8-K 2.02,9.01 0001157523-22-000932 001-35331 221111633 34 806759 1 1
2022-07-22 4 FORM 4 SUBMISSION 0000899243-22-026588 4710
2022-07-11 3 FORM 3 SUBMISSION 0000899243-22-025930 7248
2022-06-29 8-K 8-K 5.02,9.01 0001193125-22-185179 001-35331 221055568 34 166172 1 1
2022-05-20 4 FORM 4 SUBMISSION 0000899243-22-019079 4660
2022-05-20 4 FORM 4 SUBMISSION 0000899243-22-019076 4675
2022-05-20 4 FORM 4 SUBMISSION 0000899243-22-019073 4712
2022-05-20 4 FORM 4 SUBMISSION 0000899243-22-019074 4654
2022-05-20 4 FORM 4 SUBMISSION 0000899243-22-019072 4656
2022-05-20 4 FORM 4 SUBMISSION 0000899243-22-019071 4641
2022-05-20 4 FORM 4 SUBMISSION 0000899243-22-019065 6587
2022-05-20 4 FORM 4 SUBMISSION 0000899243-22-019064 4682
2022-05-20 4 FORM 4 SUBMISSION 0000899243-22-019063 4674
2022-05-20 8-K 8-K 5.07 0001193125-22-155213 001-35331 22944669 34 155094 1 1
2022-05-18 DEFA14A DEFA14A 0001140361-22-019759 001-35331 22938561 34 55678
2022-05-12 DEFA14A DEFA14A 0001140361-22-018709 001-35331 22915354 34 95980
2022-05-04 4 FORM 4 SUBMISSION 0000899243-22-016665 4573
2022-05-04 10-Q 10-Q 0001564590-22-017872 001-35331 22891948 34 11445493 1 1
2022-05-03 8-K ACADIA HEALTHCARE COMPANY, INC. 8-K 2.02,9.01 0001157523-22-000544 001-35331 22886955 34 576692 1 1
2022-04-26 4 FORM 4 SUBMISSION 0000899243-22-015689 4565
2022-04-26 4 FORM 4 SUBMISSION 0000899243-22-015688 4573
2022-04-26 4 FORM 4 SUBMISSION 0000899243-22-015687 4556
2022-04-13 4 FORM 4 SUBMISSION 0000899243-22-014749 4733
2022-04-13 4 FORM 4 SUBMISSION 0000899243-22-014748 5952
2022-04-13 4 FORM 4 SUBMISSION 0000899243-22-014747 4742
2022-04-13 4 FORM 4 SUBMISSION 0000899243-22-014746 4773
2022-04-13 4 FORM 4 SUBMISSION 0000899243-22-014745 4750
2022-04-13 3 FORM 3 SUBMISSION 0000899243-22-014744 6756
2022-04-08 DEFA14A DEFA14A 0001140361-22-013669 001-35331 22815310 34 3763568
2022-04-08 DEF 14A DEF 14A 0001140361-22-013667 001-35331 22815306 34 3323532
2022-04-04 8-K ACADIA HEALTHCARE COMPANY, INC. 8-K 5.02,9.01 0001157523-22-000389 001-35331 22803473 34 186535 1 1
2022-03-25 4 FORM 4 SUBMISSION 0000899243-22-012369 4574
2022-03-25 4 FORM 4 SUBMISSION 0000899243-22-012368 4566
2022-03-25 4 FORM 4 SUBMISSION 0000899243-22-012367 8521
2022-03-25 4 FORM 4 SUBMISSION 0000899243-22-012366 4557
2022-03-09 4 FORM 4 SUBMISSION 0000899243-22-010204 4566
2022-03-04 4 FORM 4 SUBMISSION 0000899243-22-009414 4573
2022-03-04 4 FORM 4 SUBMISSION 0000899243-22-009413 5780
2022-03-01 4 FORM 4 SUBMISSION 0000899243-22-008408 7969
2022-03-01 4 FORM 4 SUBMISSION 0000899243-22-008407 6283
2022-03-01 4 FORM 4 SUBMISSION 0000899243-22-008402 7485
2022-03-01 4 FORM 4 SUBMISSION 0000899243-22-008404 6270
2022-03-01 4 FORM 4 SUBMISSION 0000899243-22-008401 6279
2022-03-01 10-K 10-K 0001564590-22-007930 001-35331 22695923 34 20711919 1 1
2022-02-28 8-K ACADIA HEALTHCARE COMPANY, INC. 8-K 2.02,9.01 0001157523-22-000270 001-35331 22689792 34 1123280 1 1
2022-02-14 SC 13G/A achc13gadec21.txt 0000080255-22-002080 005-86704 34 9526
2022-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-22-016357 005-86704 22606232 34 13002
2022-02-08 SC 13G/A SEC SCHEDULE 13G 0000354204-22-001486 005-86704 22601012 34 19413
2022-02-04 SC 13G/A SEC SCHEDULE 13G 0001678858-22-000097 005-86704 22591238 34 37366
2022-02-03 SC 13G/A us00404a1097_020322.txt 0000834237-22-006433 005-86704 22589181 34 13466
2022-02-02 4 FORM 4 SUBMISSION 0000899243-22-004208 4552
2022-02-01 8-K 8-K 5.02,9.01 0001193125-22-024575 001-35331 22578938 34 176376 1 1
2021-10-29 10-Q 10-Q 0001564590-21-052945 001-35331 211363301 34 14256819 1 1
2021-10-28 8-K ACADIA HEALTHCARE COMPANY, INC. 8-K 2.02,9.01 0001157523-21-001282 001-35331 211358788 34 953789 1 1
2021-10-05 8-K ACADIA HEALTHCARE COMPANY, INC. 8-K 5.02,9.01 0001157523-21-001181 001-35331 211305219 34 172921 1 1
2021-08-16 4 FORM 4 SUBMISSION 0000899243-21-033124 4567
2021-08-03 S-8 S-8 0001193125-21-235080 333-258420 211140790 33 79400
2021-08-03 10-Q 10-Q 0001564590-21-040250 001-35331 211139994 34 13943448 1 1
2021-08-02 8-K ACADIA HEALTHCARE COMPANY, INC. 8-K 2.02,9.01 0001157523-21-000964 001-35331 211136177 34 897021 1 1
2021-06-16 4 FORM 4 SUBMISSION 0000899243-21-024164 9665
2021-06-16 4 FORM 4 SUBMISSION 0000899243-21-024163 4567
2021-05-07 4 FORM 4 SUBMISSION 0000899243-21-018714 4681
2021-05-07 4 FORM 4 SUBMISSION 0000899243-21-018715 4673
2021-05-07 4 FORM 4 SUBMISSION 0000899243-21-018712 4711
2021-05-07 4 FORM 4 SUBMISSION 0000899243-21-018713 4674
2021-05-07 4 FORM 4 SUBMISSION 0000899243-21-018710 4640
2021-05-07 4 FORM 4 SUBMISSION 0000899243-21-018708 6647
2021-05-07 4 FORM 4 SUBMISSION 0000899243-21-018709 4652
2021-05-07 4 FORM 4 SUBMISSION 0000899243-21-018711 4655
2021-05-07 8-K 8-K 5.02,5.07,9.01 0001193125-21-155064 001-35331 21903761 34 166158 1 1
2021-05-04 4 FORM 4 SUBMISSION 0000899243-21-018153 4572
2021-05-04 4 FORM 4 SUBMISSION 0000899243-21-018152 5780
2021-04-30 10-Q 10-Q 0001564590-21-022545 001-35331 21878316 34 12388079 1 1
2021-04-29 8-K ACADIA HEALTHCARE COMPANY, INC. 8-K 2.02,9.01 0001157523-21-000547 001-35331 21870649 34 682808 1 1
2021-04-27 4 FORM 4 SUBMISSION 0000899243-21-017119 4733
2021-04-27 4 FORM 4 SUBMISSION 0000899243-21-017118 4749
2021-04-27 4 FORM 4 SUBMISSION 0000899243-21-017117 4742
2021-04-27 4 FORM 4 SUBMISSION 0000899243-21-017116 5952
2021-03-26 4 FORM 4 SUBMISSION 0000899243-21-013702 4566
2021-03-24 DEFA14A DEFA14A 0001193125-21-092745 001-35331 21768923 34 222870
2021-03-24 DEF 14A DEF 14A 0001193125-21-092741 001-35331 21768903 34 1037378
2021-03-22 8-K 8-K 1.01,1.02,2.03,9.01 0001193125-21-088596 001-35331 21760022 34 1609718 1 1
2021-03-16 4 FORM 4 SUBMISSION 0000899243-21-011976 6063
2021-03-15 4 FORM 4 SUBMISSION 0000899243-21-011682 7248
2021-03-15 4 FORM 4 SUBMISSION 0000899243-21-011603 19887
2021-03-15 4 FORM 4 SUBMISSION 0000899243-21-011600 16478
2021-03-09 4 FORM 4 SUBMISSION 0000899243-21-010695 4566
2021-03-02 4 FORM 4 SUBMISSION 0000899243-21-009020 9011
2021-03-02 4 FORM 4 SUBMISSION 0000899243-21-009010 7805
2021-02-26 10-K 10-K 0001564590-21-009466 001-35331 21689625 34 22586002 1 1
2021-02-26 8-K ACADIA HEALTHCARE COMPANY, INC. 8-K 2.02,9.01 0001157523-21-000271 001-35331 21682067 34 1125141 1 1
2021-02-16 SC 13G/A achc13gadec20.txt 0000080255-21-001187 005-86704 34 9526
2021-02-12 SC 13G/A SEC SCHEDULE 13G 0000354204-21-000091 005-86704 21625949 34 19422
2021-02-10 SC 13G/A SCHEDULE 13G/A 0001104659-21-017326 005-86704 21609956 34 13872
2021-02-03 SC 13G/A SEC SCHEDULE 13G 0000902219-21-000055 005-86704 21585426 34 37631
2021-01-29 SC 13G/A us00404a1097_012821.txt 0000834237-21-002818 005-86704 21566794 34 13447
2021-01-22 8-K 8-K 5.02,9.01 0001193125-21-013858 001-35331 21543513 34 305518 1 1
2021-01-21 8-K 8-K 2.01,9.01 0001193125-21-013526 001-35331 21542382 34 354019 1 1
2021-01-07 8-K 8-K 1.01 0001193125-21-004146 001-35331 21514233 34 151276 1 1
2020-12-30 8-K 8-K 1.01,7.01,9.01 0001193125-20-329213 001-35331 201424193 34 183559 1 1
2020-12-16 4 FORM 4 SUBMISSION 0000899243-20-034127 6765
2020-12-11 SC 13D/A SC 13D/A 0001104659-20-134817 005-86704 201384381 34 111336
2020-11-13 8-K 8-K 1.01,2.03,9.01 0001193125-20-293046 001-35331 201311920 34 471804 1 1
2020-11-09 SC 13G/A FILING ACADIA HEALTHCARE COMPANY, INC. 0000019617-20-000461 005-86704 34 89794
2020-10-30 4 FORM 4 SUBMISSION 0000899243-20-029941 4658
2020-10-30 3 FORM 3 SUBMISSION 0000899243-20-029939 6544
2020-10-30 10-Q 10-Q 0001564590-20-049309 001-35331 201277458 34 16302206 1 1
2020-10-29 8-K ACADIA HEALTHCARE COMPANY, INC. 8-K 2.02,9.01 0001157523-20-001384 001-35331 201272843 34 838559 1 1
2020-10-28 8-K 8-K 5.02,9.01 0001193125-20-279955 001-35331 201269416 34 164200 1 1
2020-10-21 UPLOAD filename1.pdf 0000000000-20-009955 39733
2020-10-14 8-K FORM 8-K 1.01,2.03,9.01 0001193125-20-269130 001-35331 201238524 34 1296087 1 1
2020-10-08 CORRESP filename1.htm 0001564590-20-046111 34531
2020-09-29 8-K 8-K 8.01,9.01 0001193125-20-257992 001-35331 201209777 34 213225 1 1
2020-09-25 UPLOAD filename1.pdf 0000000000-20-009079 46581
2020-08-05 10-Q ACHC-10-Q-20200630 0001564590-20-036834 001-35331 201077614 34 15737646 1 1
2020-08-04 8-K ACADIA HEALTHCARE COMPANY, INC. 8-K 2.02,9.01 0001157523-20-001120 001-35331 201073692 34 841567 1 1
2020-06-24 8-K 8-K 1.01,1.02,2.03,9.01 0001193125-20-177619 001-35331 20985493 34 1285390 1 1
2020-06-12 4 FORM 4 SUBMISSION 0000899243-20-016428 9723
2020-06-10 8-K 8-K 8.01,9.01 0001193125-20-165755 001-35331 20955213 34 201404 1 1
2020-05-13 4 FORM 4 SUBMISSION 0000899243-20-012994 6788
2020-05-08 4 FORM 4 SUBMISSION 0000899243-20-012430 4674
2020-05-08 4 FORM 4 SUBMISSION 0000899243-20-012429 4742
2020-05-08 4 FORM 4 SUBMISSION 0000899243-20-012428 4640
2020-05-08 4 FORM 4 SUBMISSION 0000899243-20-012427 4712
2020-05-08 4 FORM 4 SUBMISSION 0000899243-20-012426 4704
2020-05-08 4 FORM 4 SUBMISSION 0000899243-20-012425 4686
2020-05-08 8-K 8-K 5.07 0001193125-20-137676 001-35331 20861507 34 158562 1 1
2020-05-05 10-Q 10-Q 0001564590-20-021269 001-35331 20849100 34 21178214 1 1
2020-05-04 8-K ACADIA HEALTHCARE COMPANY, INC. 8-K 2.02,9.01 0001157523-20-000644 001-35331 20845045 34 532543 1 1

Latest XBRL company facts

One latest value per concept from companyfacts (532 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 92.97M 2026-11-03 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
dei EntityPublicFloat Entity Public Float USD 2.10B 2025-06-30 2025 FY 10-K 2026-02-27 0001193125-26-078266
ffd NetFeeAmt NetFeeAmt USD 10,297.43 2026-05-11 S-8 2026-05-11 0001193125-26-217120
ffd TtlFeeAmt TtlFeeAmt USD 10,297.43 2026-05-11 S-8 2026-05-11 0001193125-26-217120
ffd TtlOfferingAmt TtlOfferingAmt USD 74.56M 2026-05-11 S-8 2026-05-11 0001193125-26-217120
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-05-11 S-8 2026-05-11 0001193125-26-217120
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 138.56M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 501.38M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap AccrualForTaxesOtherThanIncomeTaxesCurrent Accrual for Taxes Other than Income Taxes, Current USD 16.79M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap AccruedInsuranceCurrent Accrued Insurance, Current USD 50.34M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 37.27M 2017-12-31 2017 FY 10-K 2018-02-27 0001193125-18-061152
us-gaap AccumulatedAmortizationDeferredFinanceCosts Accumulated Amortization, Debt Issuance Costs USD 11.60M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 1.14B 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax USD -5.20M 2019-12-31 2019 FY 10-K 2020-02-28 0001564590-20-007769
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -371.37M 2020-12-31 2021 FY 10-K 2022-03-01 0001564590-22-007930
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 847.30M 2014-12-31 2014 FY 10-K 2015-02-27 0001193125-15-069793
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 2.74B 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap AdjustmentsToAdditionalPaidInCapitalOther Adjustments to Additional Paid in Capital, Other USD -19,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 9.25M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD -897,000 2011-01-01 2011-12-31 2011 FY 8-K 2012-10-17 0001193125-12-425224
us-gaap AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation USD 309,000 2015-01-01 2015-12-31 2017 FY 10-K 2018-02-27 0001193125-18-061152
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 2.27M 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-01 0001193125-13-087740
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 39.80M 2017-12-31 2017 FY 10-K 2018-02-27 0001193125-18-061152
us-gaap AllowanceForDoubtfulAccountsReceivableChargeOffs Allowance for Doubtful Accounts Receivable, Charge-offs (Deprecated 2013-01-31) USD 1.33M 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-01 0001193125-13-087740
us-gaap AllowanceForDoubtfulAccountsReceivableCurrent Accounts Receivable, Allowance for Credit Loss, Current USD 39.80M 2017-12-31 2017 FY 10-K 2018-02-27 0001193125-18-061152
us-gaap AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) USD 40.92M 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-27 0001193125-18-061152
us-gaap AllowanceForDoubtfulAccountsReceivableWriteOffs Accounts Receivable, Allowance for Credit Loss, Writeoff USD 40.03M 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-27 0001193125-18-061152
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 3.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 400,000 2016-01-01 2016-12-31 2017 FY 10-K 2018-02-27 0001193125-18-061152
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 1.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 10.91M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap Assets Assets USD 5.55B 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap AssetsCurrent Assets, Current USD 881.32M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap AssetsHeldForSaleNotPartOfDisposalGroup Assets Held-for-sale, Not Part of Disposal Group USD 31.10M 2019-12-31 2019 FY 10-K 2020-02-28 0001564590-20-007769
us-gaap AssetsHeldForSaleNotPartOfDisposalGroupCurrent Assets Held-for-sale, Not Part of Disposal Group, Current USD 71.20M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther Assets Held-for-sale, Not Part of Disposal Group, Current, Other USD 15.81M 2021-12-31 2021 FY 10-K 2022-03-01 0001564590-22-007930
us-gaap AssetsOfDisposalGroupIncludingDiscontinuedOperation Disposal Group, Including Discontinued Operation, Assets USD 392.48M 2016-09-30 2016 Q3 10-Q 2016-11-02 0001193125-16-757061
us-gaap AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent Disposal Group, Including Discontinued Operation, Assets, Current USD 1.81B 2020-12-31 2021 FY 10-K 2022-03-01 0001564590-22-007930
us-gaap BuildingsAndImprovementsGross Buildings and Improvements, Gross USD 2.42B 2018-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005750
us-gaap BusinessAcquisitionContingentConsiderationAtFairValue Business Acquisition, Contingent Consideration, at Fair Value (Deprecated 2013-01-31) USD 6.12M 2013-03-31 2013 Q1 10-Q 2013-05-02 0001193125-13-196184
us-gaap BusinessAcquisitionPurchasePriceAllocationAssetsAcquired Business Acquisition, Purchase Price Allocation, Assets Acquired (Deprecated 2013-01-31) USD 484.54M 2012-12-31 2012 FY 10-K 2013-03-01 0001193125-13-087740
us-gaap BusinessAcquisitionPurchasePriceAllocationAssetsAcquiredLiabilitiesAssumedNet Business Acquisition, Purchase Price Allocation, Assets Acquired (Liabilities Assumed), Net (Deprecated 2013-01-31) USD 439.56M 2012-12-31 2012 FY 10-K 2013-03-01 0001193125-13-087740
us-gaap BusinessAcquisitionPurchasePriceAllocationCurrentAssetsCashAndCashEquivalents Business Acquisition, Purchase Price Allocation, Current Assets, Cash and Cash Equivalents (Deprecated 2013-01-31) USD 1.65M 2012-12-31 2012 FY 10-K 2013-03-01 0001193125-13-087740
us-gaap BusinessAcquisitionPurchasePriceAllocationCurrentAssetsPrepaidExpenseAndOtherAssets Business Acquisition, Purchase Price Allocation, Current Assets, Prepaid Expense and Other Assets (Deprecated 2013-01-31) USD 4.95M 2012-12-31 2012 FY 10-K 2013-03-01 0001193125-13-087740
us-gaap BusinessAcquisitionPurchasePriceAllocationCurrentAssetsReceivables Business Acquisition, Purchase Price Allocation, Current Assets, Receivables (Deprecated 2013-01-31) USD 19.50M 2012-12-31 2012 FY 10-K 2013-03-01 0001193125-13-087740
us-gaap BusinessAcquisitionPurchasePriceAllocationCurrentLiabilitiesAccountsPayable Business Acquisition, Purchase Price Allocation, Current Liabilities, Accounts Payable (Deprecated 2013-01-31) USD 7.40M 2012-12-31 2012 FY 10-K 2013-03-01 0001193125-13-087740
us-gaap BusinessAcquisitionPurchasePriceAllocationCurrentLiabilitiesAccruedLiabilities Business Acquisition, Purchase Price Allocation, Current Liabilities, Accrued Liabilities (Deprecated 2013-01-31) USD 7.17M 2012-12-31 2012 FY 10-K 2013-03-01 0001193125-13-087740
us-gaap BusinessAcquisitionPurchasePriceAllocationCurrentLiabilitiesOtherLiabilities Business Acquisition, Purchase Price Allocation, Current Liabilities, Other Liabilities (Deprecated 2013-01-31) USD 3.12M 2012-12-31 2012 FY 10-K 2013-03-01 0001193125-13-087740
us-gaap BusinessAcquisitionPurchasePriceAllocationDeferredTaxLiabilitiesNoncurrent Business Acquisition, Purchase Price Allocation, Deferred Tax Liabilities, Noncurrent (Deprecated 2013-01-31) USD 419,000 2011-12-31 2012 FY 10-K 2013-03-01 0001193125-13-087740
us-gaap BusinessAcquisitionPurchasePriceAllocationGoodwillAmount Business Acquisition, Purchase Price Allocation, Goodwill Amount (Deprecated 2013-01-31) USD 369.55M 2012-12-31 2012 FY 10-K 2013-03-01 0001193125-13-087740
us-gaap BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill Business Acquisition, Purchase Price Allocation, Intangible Assets Other than Goodwill (Deprecated 2013-01-31) USD 7.98M 2012-12-31 2012 FY 10-K 2013-03-01 0001193125-13-087740
us-gaap BusinessAcquisitionPurchasePriceAllocationLiabilitiesAssumed Business Acquisition, Purchase Price Allocation, Liabilities Assumed (Deprecated 2013-01-31) USD 44.98M 2012-12-31 2012 FY 10-K 2013-03-01 0001193125-13-087740
us-gaap BusinessAcquisitionPurchasePriceAllocationNoncurrentLiabilitiesLongTermDebt Business Acquisition, Purchase Price Allocation, Noncurrent Liabilities, Long-term Debt (Deprecated 2013-01-31) USD 25.60M 2012-12-31 2012 FY 10-K 2013-03-01 0001193125-13-087740
us-gaap BusinessAcquisitionPurchasePriceAllocationOtherAssets Business Acquisition, Purchase Price Allocation, Other Assets (Deprecated 2013-01-31) USD 2.59M 2012-12-31 2012 FY 10-K 2013-03-01 0001193125-13-087740
us-gaap BusinessAcquisitionPurchasePriceAllocationOtherLiabilities Business Acquisition, Purchase Price Allocation, Other Liabilities (Deprecated 2013-01-31) USD 1.70M 2012-12-31 2012 FY 10-K 2013-03-01 0001193125-13-087740
us-gaap BusinessAcquisitionPurchasePriceAllocationPropertyPlantAndEquipment Business Acquisition, Purchase Price Allocation, Property, Plant and Equipment (Deprecated 2013-01-31) USD 78.31M 2012-12-31 2012 FY 10-K 2013-03-01 0001193125-13-087740
us-gaap BusinessAcquisitionsProFormaRevenue Business Acquisition, Pro Forma Revenue USD 2.77B 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-24 0001193125-17-056016
us-gaap BusinessCombinationAcquisitionRelatedCosts Business Combination, Acquisition Related Costs USD 68.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized Business Combination, Assets and Liabilities Arising from Contingencies, Amount Recognized, Net USD 667,000 2015-12-31 2015 FY 10-K 2016-02-26 0001193125-16-478707
us-gaap BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognizedOtherThanAtFairValue Business Combination, Assets and Liabilities Arising from Contingencies, Amount Recognized, Other than at Fair Value, Net USD 6.12M 2013-06-30 2013 Q2 10-Q 2013-07-31 0001193125-13-312513
us-gaap BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability USD 500,000 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-10-30 0001193125-14-389873
us-gaap BusinessCombinationContingentConsiderationLiability Business Combination, Contingent Consideration, Liability USD 3.47M 2014-09-30 2014 Q3 10-Q 2014-10-30 0001193125-14-389873
us-gaap BusinessExitCosts1 Business Exit Costs USD 12.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 163.31M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 120.18M 2012-06-30 2012 Q2 10-Q 2012-08-02 0001193125-12-329266
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -6.97M 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-07-31 0001564590-19-027472
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 133.81M 2021-12-31 2021 FY 10-K 2022-03-01 0001564590-22-007930
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 163.31M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 30.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations Cash Provided by (Used in) Financing Activities, Discontinued Operations USD -3.25M 2020-01-01 2020-12-31 2022 FY 10-K 2023-02-28 0001564590-23-002737
us-gaap CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations Cash Provided by (Used in) Investing Activities, Discontinued Operations USD -43.60M 2020-01-01 2020-12-31 2022 FY 10-K 2023-02-28 0001564590-23-002737
us-gaap CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations Cash Provided by (Used in) Operating Activities, Discontinued Operations USD 253,000 2021-01-01 2021-12-31 2023 FY 10-K 2024-02-28 0000950170-24-022057
us-gaap CharityCareDirectAndIndirectCostBasisAmount Charity Care, Direct and Indirect Cost Basis, Amount USD 12.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights Class of Warrant or Right, Exercise Price of Warrants or Rights (Deprecated 2014-01-31) USD/Warrant 14 2013-12-31 2013 FY 10-K 2014-02-21 0001193125-14-062774
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 0 2016-12-31 2016 FY 10-K 2017-02-24 0001193125-17-056016
us-gaap CommonStockDiscountOnShares Common Stock, Discount on Shares USD 15.80M 2016-01-12 2017 FY 10-K 2018-02-27 0001193125-18-061152
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 180.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 90.91M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 90.91M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap CommonStockValue Common Stock, Value, Issued USD 909,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -21.67M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-28 0000950170-24-022057
us-gaap ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest USD 6.01M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-28 0000950170-24-022057
us-gaap ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -15.66M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-28 0000950170-24-022057
us-gaap ConstructionInProgressGross Construction in Progress, Gross USD 294.85M 2018-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005750
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 2.21M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized USD 65.60M 2025-04-01 2025-06-30 2025 Q2 10-Q 2025-08-05 0000950170-25-103160
us-gaap CostsAndExpenses Costs and Expenses USD 2.50B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 19.41M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 416,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 24.89M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 5.06M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 2.52B 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.129 2012-12-31 2012 FY 10-K 2013-03-01 0001193125-13-087740
us-gaap DebtInstrumentPeriodicPayment Debt Instrument, Periodic Payment USD 20.00M 2019-11-15 2020 FY 10-K 2021-02-26 0001564590-21-009466
us-gaap DebtIssuanceCosts Debt Issuance Cost (Deprecated 2016-01-31) USD 37.60M 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-26 0001193125-16-478707
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD -32.25M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap DeferredFinanceCostsNet Debt Issuance Costs, Net USD 16.80M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD 117,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap DeferredIncomeTaxAssetsNet Deferred Income Tax Assets, Net USD 2.42M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap DeferredIncomeTaxesAndTaxCredits Deferred Income Taxes and Tax Credits USD 28.93M 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-04 0001193125-15-366114
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 27.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 215.35M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap DeferredIncomeTaxLiabilitiesNet Deferred Income Tax Liabilities, Net USD 93.64M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 20.25M 2022-06-30 2022 Q2 10-Q 2022-07-28 0001564590-22-026910
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 33.23M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap DeferredTaxAssetsCapitalLossCarryforwards Deferred Tax Assets, Capital Loss Carryforwards USD 216.72M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 420.65M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap DeferredTaxAssetsGrossCurrent Deferred Tax Assets, Gross, Current USD 0 2015-12-31 2015 FY 10-K 2016-02-26 0001193125-16-478707
us-gaap DeferredTaxAssetsGrossNoncurrent Deferred Tax Assets, Gross, Noncurrent USD 49.10M 2015-12-31 2015 FY 10-K 2016-02-26 0001193125-16-478707
us-gaap DeferredTaxAssetsInvestmentInSubsidiaries Deferred Tax Assets, Investment in Subsidiaries USD 239.10M 2020-12-31 2021 FY 10-K 2022-03-01 0001564590-22-007930
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 4.73M 2023-12-31 2024 FY 10-K 2025-02-27 0000950170-25-029095
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 151.27M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap DeferredTaxAssetsNetCurrent Deferred Tax Assets, Net of Valuation Allowance, Current USD 20.16M 2014-12-31 2015 FY 10-K 2016-02-26 0001193125-16-478707
us-gaap DeferredTaxAssetsNetNoncurrent Deferred Tax Assets, Net of Valuation Allowance, Noncurrent USD 3.31M 2020-03-31 2020 Q1 10-Q 2020-05-05 0001564590-20-021269
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 0 2023-12-31 2023 FY 10-K 2024-02-28 0000950170-24-022057
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsForeign Deferred Tax Assets, Operating Loss Carryforwards, Foreign USD 100,000 2023-12-31 2023 FY 10-K 2024-02-28 0000950170-24-022057
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 671.00M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 5.26M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 11.13M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 1.40M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits USD 18.55M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Pensions USD 724,000 2019-12-31 2019 FY 10-K 2020-02-28 0001564590-20-007769
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Allowance for Doubtful Accounts USD 1.45M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Legal Settlements USD 38.60M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Self Insurance USD 172,000 2012-12-31 2012 FY 10-K 2013-03-01 0001193125-13-087740
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 269.37M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap DeferredTaxExpenseFromStockOptionsExercised Deferred Tax Expense from Stock Options Exercised USD 300,000 2015-01-01 2015-12-31 2016 FY 10-K 2017-02-24 0001193125-17-056016
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 64.08M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals Deferred Tax Liabilities, Deferred Expense, Reserves and Accruals USD 4.53M 2016-12-31 2017 FY 10-K 2018-02-27 0001193125-18-061152
us-gaap DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets Deferred Tax Liabilities, Intangible Assets USD 176.26M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap DeferredTaxLiabilitiesGrossNoncurrent Deferred Tax Liabilities, Gross, Noncurrent USD 23.90M 2015-12-31 2015 FY 10-K 2016-02-26 0001193125-16-478707
us-gaap DeferredTaxLiabilitiesNoncurrent Deferred Tax Liabilities, Net, Noncurrent USD 85.41M 2020-03-31 2020 Q1 10-Q 2020-05-05 0001564590-20-021269
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 12.79M 2019-12-31 2020 FY 10-K 2021-02-26 0001564590-21-009466
us-gaap DeferredTaxLiabilitiesPrepaidExpenses Deferred Tax Liabilities, Prepaid Expenses USD 6.33M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 2.46M 2021-12-31 2022 FY 10-K 2023-02-28 0001564590-23-002737
us-gaap DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities Liability, Defined Benefit Pension Plan USD 6.30M 2014-09-30 2014 Q3 10-Q 2014-10-30 0001193125-14-389873
us-gaap DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax USD -4.10M 2017-12-31 2017 FY 10-K 2018-02-27 0001193125-18-061152
us-gaap DefinedBenefitPlanActuarialGainLoss Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss) USD 2.76M 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-27 0001193125-15-069793
us-gaap DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate pure 0.038 2015-12-31 2015 FY 10-K 2016-02-26 0001193125-16-478707
us-gaap DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase pure 0.034 2014-12-31 2015 FY 10-K 2016-02-26 0001193125-16-478707
us-gaap DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate pure 0.019 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-28 0001564590-20-007769
us-gaap DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets pure 0.019 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-28 0001564590-20-007769
us-gaap DefinedBenefitPlanBenefitObligation Defined Benefit Plan, Benefit Obligation USD 58.11M 2015-12-31 2015 FY 10-K 2016-02-26 0001193125-16-478707
us-gaap DefinedBenefitPlanBenefitsPaid Defined Benefit Plan, Benefits Paid (Deprecated 2017-01-31) USD 729,000 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-27 0001193125-15-069793
us-gaap DefinedBenefitPlanContributionsByEmployer Defined Benefit Plan, Plan Assets, Contributions by Employer USD 825,000 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-27 0001193125-15-069793
us-gaap DefinedBenefitPlanCurtailments Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Curtailment USD 1.37M 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-26 0001193125-16-478707
us-gaap DefinedBenefitPlanExpectedReturnOnPlanAssets Defined Benefit Plan, Expected Return (Loss) on Plan Assets USD 2.03M 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-26 0001193125-16-478707
us-gaap DefinedBenefitPlanFairValueOfPlanAssets Defined Benefit Plan, Plan Assets, Amount USD 55.29M 2015-12-31 2015 FY 10-K 2016-02-26 0001193125-16-478707
us-gaap DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss) USD -710,000 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-27 0001193125-15-069793
us-gaap DefinedBenefitPlanFundedStatusOfPlan Defined Benefit Plan, Funded (Unfunded) Status of Plan USD 2.82M 2015-12-31 2015 FY 10-K 2016-02-26 0001193125-16-478707
us-gaap DefinedBenefitPlanInterestCost Defined Benefit Plan, Interest Cost USD 2.37M 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-26 0001193125-16-478707
us-gaap DefinedBenefitPlanNetPeriodicBenefitCost Defined Benefit Plan, Net Periodic Benefit Cost (Credit) USD -419,000 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-26 0001193125-16-478707
us-gaap DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Plan Assets USD 57.36M 2014-12-31 2014 FY 10-K 2015-02-27 0001193125-15-069793
us-gaap DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation Defined Benefit Plan, Pension Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation USD 66.91M 2014-12-31 2014 FY 10-K 2015-02-27 0001193125-15-069793
us-gaap DefinedBenefitPlanServiceCost Defined Benefit Plan, Service Cost USD -616,000 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-26 0001193125-16-478707
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 100,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-24 0001193125-17-056016
us-gaap Depreciation Depreciation USD 189.20M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 155.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 7.83M 2013-01-01 2013-06-30 2013 Q2 10-Q 2013-07-31 0001193125-13-312513
us-gaap DerivativeInstrumentsAndHedgesLiabilitiesNoncurrent Derivative Instruments and Hedges, Liabilities, Noncurrent USD 68.92M 2019-12-31 2020 FY 10-K 2021-02-26 0001564590-21-009466
us-gaap DerivativeInstrumentsAndHedgesNoncurrent Derivative Instruments and Hedges, Noncurrent USD 60.52M 2018-12-31 2019 FY 10-K 2020-02-28 0001564590-20-007769
us-gaap DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value USD 13.73M 2014-06-30 2014 Q2 10-Q 2014-07-30 0001193125-14-286882
us-gaap DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net USD 500,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-24 0001193125-17-056016
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 84.58M 2020-12-31 2021 FY 10-K 2022-03-01 0001564590-22-007930
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 15.16M 2018-03-31 2018 Q1 10-Q 2018-05-03 0001193125-18-150794
us-gaap DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax USD -14.30M 2021-01-01 2021-03-31 2023 FY 10-K 2024-02-28 0000950170-24-022057
us-gaap DiscontinuedOperationTaxEffectOfDiscontinuedOperation Discontinued Operation, Tax Effect of Discontinued Operation USD -88,000 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-26 0001193125-16-478707
us-gaap DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent Disposal Group, Including Discontinued Operation, Assets, Noncurrent USD 2.53B 2019-12-31 2020 FY 10-K 2021-02-26 0001564590-21-009466
us-gaap DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss Disposal Group, Including Discontinued Operation, Operating Income (Loss) USD -200,000 2012-01-01 2012-12-31 2014 FY 10-K 2015-02-27 0001193125-15-069793
us-gaap DisposalGroupIncludingDiscontinuedOperationRevenue Disposal Group, Including Discontinued Operation, Revenue USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-26 0001193125-16-478707
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares 0.55 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares 0.1 2012-10-01 2012-12-31 2013 FY 10-K 2014-02-21 0001193125-14-062774
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares 0.54 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0.381 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure -0.032 2020-01-01 2020-12-31 2022 FY 10-K 2023-02-28 0001564590-23-002737
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense Effective Income Tax Rate Reconciliation, Noncontrolling Interest Income (Loss), Percent pure 0.006 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Percent pure -0.196 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.003 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure -0.035 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingenciesForeign Effective Income Tax Rate Reconciliation, Tax Contingency, Foreign, Percent pure 0.392 2016-01-01 2016-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005750
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure -0.004 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent Effective Income Tax Rate Reconciliation, Tax Cuts and Jobs Act, Percent pure -16.4 2018-01-01 2018-12-31 2020 FY 10-K 2021-02-26 0001564590-21-009466
us-gaap EffectOfExchangeRateOnCashAndCashEquivalents Effect of Exchange Rate on Cash and Cash Equivalents USD -221,000 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-07-31 0001564590-19-027472
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 4.07M 2021-01-01 2021-12-31 2023 FY 10-K 2024-02-28 0000950170-24-022057
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 184.39M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards Share-based Payment Arrangement, Cash Used to Settle Award USD 1.03M 2011-01-01 2011-12-31 2013 FY 10-K 2014-02-21 0001193125-14-062774
us-gaap EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense Share-based Payment Arrangement, Expense, Tax Benefit USD 8.02M 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-04 0001193125-15-366114
us-gaap EquityMethodInvestmentOwnershipPercentage Equity Method Investment, Ownership Percentage pure 1 2014-06-30 2014 Q2 10-Q 2014-07-30 0001193125-14-286882
us-gaap ExcessTaxBenefitFromShareBasedCompensationFinancingActivities Excess Tax Benefit from Share-based Compensation, Financing Activities USD 309,000 2015-01-01 2015-12-31 2017 FY 10-K 2018-02-27 0001193125-18-061152
us-gaap ExtinguishmentOfDebtAmount Extinguishment of Debt, Amount USD 9.35M 2013-01-01 2013-09-30 2014 Q3 10-Q 2014-10-30 0001193125-14-389873
us-gaap FairValueOfAssetsAcquired Fair Value of Assets Acquired USD 33.59M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap FinanceLeaseInterestExpense Finance Lease, Interest Expense USD 999,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap FinanceLeaseInterestPaymentOnLiability Finance Lease, Interest Payment on Liability USD 999,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap FinanceLeaseLiability Finance Lease, Liability USD 11.80M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap FinanceLeaseLiabilityCurrent Finance Lease, Liability, Current USD 1.09M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap FinanceLeaseLiabilityNoncurrent Finance Lease, Liability, Noncurrent USD 10.71M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap FinanceLeaseLiabilityPaymentsDue Finance Lease, Liability, Payment, Due USD 24.00M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap FinanceLeaseLiabilityPaymentsDueAfterYearFive Finance Lease, Liability, to be Paid, after Year Five USD 18.43M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap FinanceLeaseLiabilityPaymentsDueNextTwelveMonths Finance Lease, Liability, to be Paid, Year One USD 1.09M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap FinanceLeaseLiabilityPaymentsDueYearFive Finance Lease, Liability, to be Paid, Year Five USD 1.20M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap FinanceLeaseLiabilityPaymentsDueYearFour Finance Lease, Liability, to be Paid, Year Four USD 1.11M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap FinanceLeaseLiabilityPaymentsDueYearThree Finance Lease, Liability, to be Paid, Year Three USD 1.09M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap FinanceLeaseLiabilityPaymentsDueYearTwo Finance Lease, Liability, to be Paid, Year Two USD 1.09M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear Finance Lease, Liability, to be Paid, Remainder of Fiscal Year USD 1.96M 2020-09-30 2020 Q3 10-Q 2020-10-30 0001564590-20-049309
us-gaap FinanceLeaseLiabilityUndiscountedExcessAmount Finance Lease, Liability, Undiscounted Excess Amount USD 12.20M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 31.14M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0001564590-22-007930
us-gaap FinanceLeaseRightOfUseAsset Finance Lease, Right-of-Use Asset, after Accumulated Amortization USD 7.05M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap FinanceLeaseRightOfUseAssetAmortization Finance Lease, Right-of-Use Asset, Amortization USD 375,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap FinanceLeaseWeightedAverageDiscountRatePercent Finance Lease, Weighted Average Discount Rate, Percent pure 0.051 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 1.13M 2020-12-31 2020 FY 10-K 2021-02-26 0001564590-21-009466
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths Finite-Lived Intangible Assets, Amortization Expense, Next Rolling Twelve Months USD 400,000 2016-09-30 2016 Q3 10-Q 2016-11-02 0001193125-16-757061
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 500,000 2014-06-30 2014 Q2 10-Q 2014-07-30 0001193125-14-286882
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year USD 500,000 2015-09-30 2015 Q3 10-Q 2015-11-04 0001193125-15-366114
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Five USD 0 2016-09-30 2016 Q3 10-Q 2016-11-02 0001193125-16-757061
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Four USD 0 2016-09-30 2016 Q3 10-Q 2016-11-02 0001193125-16-757061
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Three USD 0 2016-09-30 2016 Q3 10-Q 2016-11-02 0001193125-16-757061
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Two USD 0 2016-09-30 2016 Q3 10-Q 2016-11-02 0001193125-16-757061
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 0 2014-06-30 2014 Q2 10-Q 2014-07-30 0001193125-14-286882
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 0 2014-06-30 2014 Q2 10-Q 2014-07-30 0001193125-14-286882
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 400,000 2014-06-30 2014 Q2 10-Q 2014-07-30 0001193125-14-286882
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 500,000 2014-06-30 2014 Q2 10-Q 2014-07-30 0001193125-14-286882
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 1.13M 2020-12-31 2020 FY 10-K 2021-02-26 0001564590-21-009466
us-gaap ForeignCurrencyContractAssetFairValueDisclosure Foreign Currency Contract, Asset, Fair Value Disclosure USD 60.50M 2018-12-31 2019 FY 10-K 2020-02-28 0001564590-20-007769
us-gaap ForeignCurrencyContractsLiabilityFairValueDisclosure Foreign Currency Contracts, Liability, Fair Value Disclosure USD 84.60M 2020-12-31 2021 FY 10-K 2022-03-01 0001564590-22-007930
us-gaap GainLossOnDispositionOfAssets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property USD 3.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap GainLossOnDispositionOfIntangibleAssets Gain (Loss) on Disposition of Intangible Assets USD 100,000 2021-10-01 2021-12-31 2023 FY 10-K 2024-02-28 0000950170-24-022057
us-gaap GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments USD 523,000 2016-01-01 2016-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005750
us-gaap GainLossOnSaleOfBusiness Gain (Loss) on Disposition of Business USD -178.81M 2016-01-01 2016-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005750
us-gaap GainLossRelatedToLitigationSettlement Gain (Loss) Related to Litigation Settlement USD -13.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD -1.27M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 177.60M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap Goodwill Goodwill USD 1.32B 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap GoodwillAcquiredDuringPeriod Goodwill, Acquired During Period USD 19.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap GoodwillAndIntangibleAssetImpairment Goodwill and Intangible Asset Impairment USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-28 0001564590-20-007769
us-gaap GoodwillForeignCurrencyTranslationGainLoss Goodwill, Foreign Currency Translation Gain (Loss) USD -8.67M 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-10-30 0001564590-20-049309
us-gaap GoodwillGross Goodwill, Gross USD 2.79B 2020-09-30 2020 Q3 10-Q 2020-10-30 0001564590-20-049309
us-gaap GoodwillImpairedAccumulatedImpairmentLoss Goodwill, Impaired, Accumulated Impairment Loss USD 325.88M 2020-09-30 2020 Q3 10-Q 2020-10-30 0001564590-20-049309
us-gaap GoodwillImpairmentLoss Goodwill, Impairment Loss USD 996.20M 2025-01-01 2025-12-31 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap GoodwillOtherChanges Goodwill, Other Changes (Deprecated 2016-01-31) USD -2.41M 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-04-29 0001193125-16-569477
us-gaap GoodwillPurchaseAccountingAdjustments Goodwill, Purchase Accounting Adjustments USD 389,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-05 0001193125-25-267062
us-gaap GoodwillTranslationAdjustments Goodwill, Translation Adjustments (Deprecated 2016-01-31) USD -11.41M 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-04-29 0001193125-16-569477
us-gaap GoodwillTranslationAndPurchaseAccountingAdjustments Goodwill, Translation and Purchase Accounting Adjustments USD 8.76M 2022-01-01 2022-12-31 2023 FY 10-K 2024-02-28 0000950170-24-022057
us-gaap GoodwillWrittenOffRelatedToSaleOfBusinessUnit Goodwill, Written off Related to Sale of Business Unit USD 700,000 2021-10-01 2021-12-31 2023 FY 10-K 2024-02-28 0000950170-24-022057
us-gaap HealthCareOrganizationMedicalSuppliesAndDrugsExpense Health Care Organization, Medical Supplies and Drugs Expense (Deprecated 2018-01-31) USD 29.36M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-03 0001193125-18-150794
us-gaap HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts Health Care Organization, Patient Service Revenue Provision for Bad Debts USD 10.15M 2017-01-01 2017-03-31 2018 Q1 10-Q 2018-05-03 0001193125-18-150794
us-gaap HealthCareOrganizationRevenue Health Care Organization, Revenue (Deprecated 2018-01-31) USD 742.24M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-03 0001193125-18-150794
us-gaap HealthCareOrganizationRevenueNetOfPatientServiceRevenueProvisions Health Care Organization, Revenue Net of Patient Service Revenue Provisions USD 2.27B 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-06 0001564590-18-027458
us-gaap ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) USD 300,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2024-10-01 2024 FY 10-K 2025-02-27 0000950170-25-029095
us-gaap ImpairmentOfLongLivedAssetsToBeDisposedOf Impairment of Long-Lived Assets to be Disposed of USD 1.10M 2021-07-01 2021-09-30 2023 FY 10-K 2024-02-28 0000950170-24-022057
us-gaap IncomeLossFromContinuingOperations Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent USD -21.67M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-28 0000950170-24-022057
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD 89.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD 32.48M 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-04-29 0001193125-16-569477
us-gaap IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -15.66M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-28 0000950170-24-022057
us-gaap IncomeLossFromContinuingOperationsPerBasicShare Income (Loss) from Continuing Operations, Per Basic Share USD/shares -0.24 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-28 0000950170-24-022057
us-gaap IncomeLossFromContinuingOperationsPerDilutedShare Income (Loss) from Continuing Operations, Per Diluted Share USD/shares -0.24 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-28 0000950170-24-022057
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTax Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -12.64M 2021-01-01 2021-12-31 2023 FY 10-K 2024-02-28 0000950170-24-022057
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent USD -12.64M 2021-01-01 2021-12-31 2023 FY 10-K 2024-02-28 0000950170-24-022057
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share USD/shares -0.14 2021-01-01 2021-12-31 2023 FY 10-K 2024-02-28 0000950170-24-022057
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share USD/shares -0.14 2021-01-01 2021-12-31 2023 FY 10-K 2024-02-28 0000950170-24-022057
us-gaap IncomeLossFromEquityMethodInvestments Income (Loss) from Equity Method Investments USD 0 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-10-30 0001193125-14-389873
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 30.09M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap IncomeTaxesReceivable Income Taxes Receivable, Current USD 39.12M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap IncomeTaxExaminationPenaltiesAndInterestExpense Income Tax Examination, Penalties and Interest Expense USD 300,000 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-26 0001193125-16-478707
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 34.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD 22.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap IncomeTaxPaidForeignAfterRefundReceived IncomeTaxPaidForeignAfterRefundReceived USD 481,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap IncomeTaxReceivable Income Taxes Receivable USD 41.90M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD -69,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD 116,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -223.85M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Amount USD 209.20M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 3.80M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD -714,000 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-01 0001193125-13-087740
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD -93,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 36.82M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap IncomeTaxReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Amount USD 4.71M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 5.69M 2011-01-01 2011-09-30 2011 Q3 10-Q 2011-11-14 0001193125-11-311297
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 36.31M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 60.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap IncreaseDecreaseInEmployeeRelatedLiabilities Increase (Decrease) in Employee Related Liabilities USD -10.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap IncreaseDecreaseInOtherAccruedLiabilities Increase (Decrease) in Other Accrued Liabilities USD 544,000 2011-01-01 2011-09-30 2011 Q3 10-Q 2011-11-14 0001193125-11-311297
us-gaap IncreaseDecreaseInOtherCurrentAssets Increase (Decrease) in Other Current Assets USD -43.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap IncreaseDecreaseInOtherCurrentLiabilities Increase (Decrease) in Other Current Liabilities USD 35.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD 1.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD -661,000 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-07-31 0001564590-19-027472
us-gaap IndefiniteLivedIntangibleAssetsExcludingGoodwill Indefinite-lived Intangible Assets (Excluding Goodwill) USD 100.19M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap IndefiniteLivedIntangibleAssetsPurchaseAccountingAdjustments Indefinite-lived Intangible Assets, Purchase Accounting Adjustments USD -40,000 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-10-30 0001564590-20-049309
us-gaap InsuranceReceivableForMalpractice Insurance Receivable for Malpractice USD 25.20M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap InsuranceReceivableForMalpracticeCurrent Insurance Receivable for Malpractice, Current USD 222,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap InsuranceReceivableForMalpracticeNoncurrent Insurance Receivable for Malpractice, Noncurrent USD 25.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap InsuranceSettlementsReceivableCurrent Insurance Settlements Receivable, Current USD 3.35M 2012-12-31 2012 FY 10-K 2013-03-01 0001193125-13-087740
us-gaap IntangibleAssetsGrossExcludingGoodwill Intangible Assets, Gross (Excluding Goodwill) USD 74.27M 2024-09-30 2024 Q3 10-Q 2024-10-30 0000950170-24-119044
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 100.19M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap InterestExpense Interest Expense USD 27.67M 2013-01-01 2013-09-30 2013 Q3 10-Q 2013-10-30 0001193125-13-418667
us-gaap InterestIncomeExpenseNet Interest Income (Expense), Net USD -113.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 175.20M 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005750
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 124.66M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap InterestPayableCurrent Interest Payable, Current USD 19.16M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap InterestPayableCurrentAndNoncurrent Interest Payable USD 5.10M 2013-12-31 2013 FY 10-K 2014-02-21 0001193125-14-062774
us-gaap InventoryNet Inventory, Net USD 6.25M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap InvestmentAdvisoryFees Investment Advisory Fees (Deprecated 2018-01-31) USD 350,000 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-01 0001193125-13-087740
us-gaap LaborAndRelatedExpense Labor and Related Expense USD 1.43B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap Land Land USD 430.77M 2018-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005750
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 28.69M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-10-29 0001564590-21-052945
us-gaap LeaseCost Lease, Cost USD 49.40M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 196.27M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 81.94M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 28.16M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 16.41M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 20.25M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 23.27M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 26.25M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 15.77M 2020-09-30 2020 Q3 10-Q 2020-10-30 0001564590-20-049309
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 53.15M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap Liabilities Liabilities USD 3.30B 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 5.55B 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap LiabilitiesAssumed1 Liabilities Assumed USD 1.19M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap LiabilitiesCurrent Liabilities, Current USD 552.03M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent Disposal Group, Including Discontinued Operation, Liabilities, Current USD 660.03M 2020-12-31 2021 FY 10-K 2022-03-01 0001564590-22-007930
us-gaap LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent USD 487.08M 2019-12-31 2020 FY 10-K 2021-02-26 0001564590-21-009466
us-gaap LimitedPartnersCapitalAccountDistributionAmount Limited Partners' Capital Account, Distribution Amount USD 375,000 2011-01-01 2011-12-31 2013 FY 10-K 2014-02-21 0001193125-14-062774
us-gaap LineOfCreditFacilityIncreaseAdditionalBorrowings Line of Credit Facility, Increase, Additional Borrowings (Deprecated 2013-01-31) USD 50.00M 2013-01-01 2013-03-31 2013 Q1 10-Q 2013-05-02 0001193125-13-196184
us-gaap LineOfCreditFacilityIncreaseDecreaseForPeriodNet Line of Credit Facility, Increase (Decrease), Net USD 0 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-08 0001193125-12-460463
us-gaap LineOfCreditFacilityMaximumBorrowingCapacity Line of Credit Facility, Maximum Borrowing Capacity USD 75.00M 2012-09-30 2012 Q3 10-Q 2012-11-08 0001193125-12-460463
us-gaap LineOfCreditFacilityRemainingBorrowingCapacity Line of Credit Facility, Remaining Borrowing Capacity USD 135.60M 2014-09-30 2014 Q3 10-Q 2014-10-30 0001193125-14-389873
us-gaap LitigationSettlementAmountAwardedToOtherParty Litigation Settlement, Amount Awarded to Other Party USD 400.00M 2024-01-19 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap LitigationSettlementExpense Litigation Settlement, Expense USD 6.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap LongTermDebt Long-term Debt USD 2.35B 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 32.50M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap LongTermDebtFairValue Long-term Debt, Fair Value USD 175.90M 2012-09-30 2012 Q3 10-Q 2012-11-08 0001193125-12-460463
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive Long-Term Debt, Maturity, after Year Five USD 550.00M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 28.44M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive Long-Term Debt, Maturity, Year Five USD 875.25M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour Long-Term Debt, Maturity, Year Four USD 535.94M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 494.69M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 32.50M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 2.32B 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap LossContingencyAccrualCarryingValueCurrent Loss Contingency, Accrual, Current USD 19.90M 2024-09-30 2024 Q3 10-Q 2024-10-30 0000950170-24-119044
us-gaap MachineryAndEquipmentGross Machinery and Equipment, Gross USD 444.54M 2018-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005750
us-gaap MalpracticeInsuranceAnnualCoverageLimit Malpractice Insurance, Annual Coverage Limit USD 75.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap MalpracticeInsuranceDeductible Malpractice Insurance, Deductible (Deprecated 2013-01-31) USD 50,000 2012-12-31 2012 FY 10-K 2013-03-01 0001193125-13-087740
us-gaap MalpracticeInsuranceDeductible1 Malpractice Insurance, Deductible USD 250,000 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-27 0001193125-15-069793
us-gaap MalpracticeInsuranceMaximumCoveragePerIncident Malpractice Insurance, Maximum Coverage Per Incident USD 5.00M 2022-09-01 2022-09-30 2022 Q3 10-Q 2022-11-02 0001564590-22-036269
us-gaap MalpracticeLossContingencyAccrualUndiscounted Malpractice Loss Contingency, Accrual, Undiscounted USD 214.70M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap MalpracticeLossContingencyAccrualUndiscountedCurrent Malpractice Loss Contingency, Accrual, Undiscounted, Current USD 50.30M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap MalpracticeLossContingencyAccrualUndiscountedNoncurrent Malpractice Loss Contingency, Accrual, Undiscounted, Noncurrent USD 164.40M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap ManagementFeeAmountPaid Management Fee, Amount Paid (Deprecated 2013-01-31) USD 1.30M 2011-01-01 2011-12-31 2012 FY 10-K 2013-03-01 0001193125-13-087740
us-gaap MinorityInterest Stockholders' Equity Attributable to Noncontrolling Interest USD 22.42M 2017-12-31 2017 FY 10-K 2018-02-27 0001193125-18-061152
us-gaap MinorityInterestOwnershipPercentageByParent Noncontrolling Interest, Ownership Percentage by Parent pure 1 2016-09-30 2016 Q3 10-Q 2016-11-02 0001193125-16-757061
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD -156.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD -110.90M 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-28 0001564590-23-002737
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -135.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -305.83M 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-28 0001564590-23-002737
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD 321.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD 462.34M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-28 0000950170-24-022057
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD 49.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap NetIncomeLossAttributableToNoncontrollingInterest Net Income (Loss) Attributable to Noncontrolling Interest USD 5.86M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap NetIncomeLossAttributableToRedeemableNoncontrollingInterest Net Income (Loss) Attributable to Redeemable Noncontrolling Interest USD 5.86M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification (Deprecated 2020-01-31) USD 8.60M 2017-01-01 2017-12-31 2019 FY 10-K 2020-02-28 0001564590-20-007769
us-gaap NoncontrollingInterestIncreaseFromBusinessCombination Noncontrolling Interest, Increase from Business Combination USD 6.73M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0001564590-22-007930
us-gaap NotesAndLoansReceivableNetCurrent Financing Receivable, after Allowance for Credit Loss, Current USD 11.88M 2019-09-30 2019 Q3 10-Q 2019-11-06 0001564590-19-041035
us-gaap NumberOfForeignCurrencyDerivativesHeld Number of Foreign Currency Derivatives Held Contract 2 2014-06-30 2014 FY 10-K 2015-02-27 0001193125-15-069793
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2020-12-01 2020-12-31 2020 FY 10-K 2021-02-26 0001564590-21-009466
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap NumberOfReportingUnits Number of Reporting Units Segment 1 2024-10-01 2024 FY 10-K 2025-02-27 0000950170-25-029095
us-gaap NumberOfStatesInWhichEntityOperates Number of States in which Entity Operates State 40 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap OperatingExpenses Operating Expenses USD 742.95M 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-05 0001564590-20-021269
us-gaap OperatingIncomeLoss Operating Income (Loss) USD 132.85M 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-05 0001564590-20-021269
us-gaap OperatingLeaseCost Operating Lease, Cost USD 32.90M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 35.51M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 143.12M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 21.74M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 129.55M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap OperatingLeasePayments Operating Lease, Payments USD 33.98M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 139.14M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 1.06B 2018-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005750
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 64.96M 2018-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005750
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 47.68M 2018-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005750
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 51.57M 2018-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005750
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 57.20M 2018-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005750
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 61.70M 2018-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005750
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 777.68M 2018-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005750
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.065 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap OperatingLossCarryforwardsValuationAllowance Operating Loss Carryforwards, Valuation Allowance USD 239.10M 2020-12-31 2020 FY 10-K 2021-02-26 0001564590-21-009466
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 174.84M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap OtherAssetsCurrent Other Assets, Current USD 216.62M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap OtherAssetsMiscellaneousCurrent Other Assets, Miscellaneous, Current USD 5.67M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 67.24M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap OtherComprehensiveIncomeDerivativesQualifyingAsHedgesTaxPortionAttributableToParent Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax, Portion Attributable to Parent USD 16.30M 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-05 0001564590-20-021269
us-gaap OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax USD 19,000 2021-01-01 2021-12-31 2023 FY 10-K 2024-02-28 0000950170-24-022057
us-gaap OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax USD 100,000 2021-01-01 2021-12-31 2023 FY 10-K 2024-02-28 0000950170-24-022057
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD -4.26M 2021-01-01 2021-12-31 2023 FY 10-K 2024-02-28 0000950170-24-022057
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD 371.37M 2021-01-01 2021-12-31 2023 FY 10-K 2024-02-28 0000950170-24-022057
us-gaap OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax USD 6.46M 2020-01-01 2020-12-31 2022 FY 10-K 2023-02-28 0001564590-23-002737
us-gaap OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-28 0001564590-23-002737
us-gaap OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax USD 43.75M 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-05 0001564590-20-021269
us-gaap OtherCostAndExpenseOperating Other Cost and Expense, Operating USD 422.56M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 7.82M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 207.15M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap OtherLongTermDebt Other Long-term Debt USD 3.63M 2020-12-31 2021 FY 10-K 2022-03-01 0001564590-22-007930
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD -639,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap OtherOperatingIncome Other Operating Income USD 18.07M 2020-07-01 2020-09-30 2021 Q3 10-Q 2021-10-29 0001564590-21-052945
us-gaap OtherReceivablesNetCurrent Other Receivables, Net, Current USD 17.55M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap OtherSignificantNoncashTransactionValueOfConsiderationGiven1 Other Significant Noncash Transaction, Value of Consideration Given USD 1.47M 2014-01-01 2014-12-31 2016 FY 10-K 2017-02-24 0001193125-17-056016
us-gaap OtherSundryLiabilitiesCurrent Other Sundry Liabilities, Current USD 8.59M 2016-09-30 2016 Q3 10-Q 2016-11-02 0001193125-16-757061
us-gaap PartnersCapital Partners' Capital USD 25.11M 2010-12-31 2013 FY 10-K 2014-02-21 0001193125-14-062774
us-gaap PartnersCapitalAccountContributions Partners' Capital Account, Contributions USD 51.03M 2011-01-01 2011-12-31 2013 FY 10-K 2014-02-21 0001193125-14-062774
us-gaap PartnersCapitalAccountUnitBasedCompensation Partners' Capital Account, Unit-based Payment Arrangement, Amount USD 19.84M 2011-01-01 2011-09-30 2011 Q3 10-Q 2011-11-14 0001193125-11-311297
us-gaap PartnersCapitalOther Partners' Capital, Other USD -74.44M 2011-01-01 2011-12-31 2013 FY 10-K 2014-02-21 0001193125-14-062774
us-gaap PaymentForContingentConsiderationLiabilityFinancingActivities Payment for Contingent Consideration Liability, Financing Activities USD 1.50M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap PaymentsForProceedsFromDerivativeInstrumentInvestingActivities Payments for (Proceeds from) Derivative Instrument, Investing Activities USD 84.80M 2021-01-01 2021-12-31 2023 FY 10-K 2024-02-28 0000950170-24-022057
us-gaap PaymentsForProceedsFromOtherInvestingActivities Payments for (Proceeds from) Other Investing Activities USD 3.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 50.03M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap PaymentsForRepurchaseOfRedeemableNoncontrollingInterest Payments for Repurchase of Redeemable Noncontrolling Interest USD 5.54M 2022-01-01 2022-12-31 2024 FY 10-K 2025-02-27 0000950170-25-029095
us-gaap PaymentsOfCapitalDistribution Payments of Capital Distribution USD 74.44M 2011-01-01 2011-12-31 2013 FY 10-K 2014-02-21 0001193125-14-062774
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 18.61M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap PaymentsOfDistributionsToAffiliates Payments of Distributions to Affiliates USD 4.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap PaymentsOfDividendsMinorityInterest Payments of Ordinary Dividends, Noncontrolling Interest USD 4.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 700,000 2016-01-12 2017 FY 10-K 2018-02-27 0001193125-18-061152
us-gaap PaymentsToAcquireBusinessesNetOfCashAcquired Payments to Acquire Businesses, Net of Cash Acquired USD 8.16M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 165.86M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap PaymentsToAcquireRealEstate Payments to Acquire Real Estate USD 4.45M 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-07-31 0001564590-19-027472
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2014-06-30 2014 Q2 10-Q 2014-07-30 0001193125-14-286882
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 51.10M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap ProceedsAndExcessTaxBenefitFromSharebasedCompensation Proceeds and Excess Tax Benefit from Share-based Compensation USD 1.21M 2013-01-01 2013-06-30 2013 Q2 10-Q 2013-07-31 0001193125-13-312513
us-gaap ProceedsFromContributionsFromAffiliates Proceeds from Contributions from Affiliates USD 2.76M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap ProceedsFromContributionsFromParent Proceeds from Contributions from Parent USD 51.03M 2011-01-01 2011-12-31 2013 FY 10-K 2014-02-21 0001193125-14-062774
us-gaap ProceedsFromDivestitureOfBusinesses Proceeds from Divestiture of Businesses USD 1.51B 2021-01-01 2021-12-31 2023 FY 10-K 2024-02-28 0000950170-24-022057
us-gaap ProceedsFromDividendsReceived Proceeds from Dividends Received USD 36.64M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap ProceedsFromIncomeTaxRefunds Proceeds from Income Tax Refunds USD 22.80M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0001564590-22-007930
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 216.88M 2016-01-01 2016-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005750
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 1.20B 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 44.02M 2011-01-01 2011-12-31 2013 FY 10-K 2014-02-21 0001193125-14-062774
us-gaap ProceedsFromLinesOfCredit Proceeds from Lines of Credit USD 40.00M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-03 0000950170-23-058814
us-gaap ProceedsFromLongTermLinesOfCredit Proceeds from Long-term Lines of Credit USD 468.00M 2015-01-01 2015-12-31 2015 FY 10-K 2016-02-26 0001193125-16-478707
us-gaap ProceedsFromMinorityShareholders Proceeds from Noncontrolling Interests USD 4.18M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-28 0000950170-24-022057
us-gaap ProceedsFromPaymentsForOtherFinancingActivities Proceeds from (Payments for) Other Financing Activities USD -107,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap ProceedsFromRepurchaseOfEquity Proceeds from (Repurchase of) Equity USD 374.43M 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-27 0001193125-15-069793
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 33.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 233,000 2013-01-01 2013-09-30 2013 Q3 10-Q 2013-10-30 0001193125-13-418667
us-gaap ProfessionalAndContractServicesExpense Professional and Contract Services Expense USD 20.60M 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-01 0001193125-13-087740
us-gaap ProfessionalFees Professional Fees USD 167.62M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD 55.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 4.19B 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 3.05B 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap ProvisionForDoubtfulAccounts Accounts Receivable, Credit Loss Expense (Reversal) USD 4.49M 2013-01-01 2013-03-31 2013 Q1 10-Q 2013-05-02 0001193125-13-196184
us-gaap ReclassificationsOfTemporaryToPermanentEquity Reclassifications of Temporary to Permanent Equity USD 365,000 2011-01-01 2011-12-31 2013 FY 10-K 2014-02-21 0001193125-14-062774
us-gaap RedeemableNoncontrollingInterestEquityCarryingAmount Redeemable Noncontrolling Interest, Equity, Carrying Amount USD 229.88M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap ReinsuranceRetentionExcessRetentionAmountReinsuredPerPolicy ReinsuranceRetentionExcessRetentionAmountReinsuredPerPolicy USD 10.00M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-02 0001564590-22-036269
us-gaap ReinsuranceRetentionPolicyAmountRetained Reinsurance Retention Policy, Amount Retained USD 3.00M 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-10-25 0001193125-17-319331
us-gaap ReinsuranceRetentionPolicyExcessRetentionAmountReinsured Reinsurance Retention Policy, Excess Retention, Amount Reinsured USD 75.00M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-03 0001193125-18-150794
us-gaap RepaymentsOfDebt Repayments of Debt USD 1.35B 2016-01-01 2016-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005750
us-gaap RepaymentsOfLongTermDebt Repayments of Long-term Debt USD 21.92M 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005750
us-gaap RepaymentsOfLongTermLinesOfCredit Repayments of Long-term Lines of Credit USD 215.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 97.50M 2015-01-01 2015-12-31 2016 FY 10-K 2017-02-24 0001193125-17-056016
us-gaap RepaymentsOfOtherLongTermDebt Repayments of Other Long-term Debt USD 3.30M 2021-01-01 2021-12-31 2023 FY 10-K 2024-02-28 0000950170-24-022057
us-gaap RepaymentsOfSecuredDebt Repayments of Secured Debt USD 20.31M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap RepaymentsOfSeniorDebt Repayments of Senior Debt USD 670.86M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -716.32M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 2.59B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability Right-of-Use Asset Obtained in Exchange for Finance Lease Liability USD 2.90M 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-10-30 0001564590-20-049309
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 43.79M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap SeveranceCosts Severance Costs (Deprecated 2013-01-31) USD 469,000 2013-01-01 2013-03-31 2013 Q1 10-Q 2013-05-02 0001193125-13-196184
us-gaap SeveranceCosts1 Severance Costs USD 14.71M 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-27 0001193125-18-061152
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 28.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost Share-based Payment Arrangement, Accelerated Cost USD 600,000 2013-01-01 2013-12-31 2013 FY 10-K 2014-02-21 0001193125-14-062774
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number shares 20,090 2013-01-01 2013-12-31 2013 FY 10-K 2014-02-21 0001193125-14-062774
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 6,000 2013-01-01 2013-03-31 2013 Q1 10-Q 2013-05-02 0001193125-13-196184
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 205,300 2013-01-01 2013-03-31 2013 Q1 10-Q 2013-05-02 0001193125-13-196184
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 29.09 2013-01-01 2013-03-31 2013 Q1 10-Q 2013-05-02 0001193125-13-196184
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 476,978 2013-03-31 2013 Q1 10-Q 2013-05-02 0001193125-13-196184
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 21.48 2013-03-31 2013 Q1 10-Q 2013-05-02 0001193125-13-196184
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 40,385 2013-01-01 2013-03-31 2013 Q1 10-Q 2013-05-02 0001193125-13-196184
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value USD/shares 15.73 2013-01-01 2013-03-31 2013 Q1 10-Q 2013-05-02 0001193125-13-196184
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.33 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.044 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized shares 18.18M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 4.93M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 3.96M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 656,767 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 39.04 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 7.78M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-02 0001564590-22-036269
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 62,935 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 63.32 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 1.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 27.24 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 17.80M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 1.57M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 24.73 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 20,842 2011-11-01 2013 FY 10-K 2014-02-21 0001193125-14-062774
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 30.63 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 11.68 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 3.98M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap SponsorFees Sponsor Fees USD 1.35M 2011-01-01 2011-12-31 2013 FY 10-K 2014-02-21 0001193125-14-062774
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 2.02B 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 253.56M 2012-09-30 2012 Q3 10-Q 2012-11-08 0001193125-12-460463
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 2,300 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 44.02M 2011-01-01 2011-12-31 2013 FY 10-K 2014-02-21 0001193125-14-062774
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 901.98M 2016-01-01 2016-12-31 2018 FY 10-K 2019-03-01 0001564590-19-005750
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 70,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap StockRepurchasedAndRetiredDuringPeriodValue Stock Repurchased and Retired During Period, Value USD -4,000 2025-10-01 2025-12-31 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap SuppliesExpense Supplies Expense USD 91.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap TaxBenefitFromStockOptionsExercised1 Tax Benefit from Stock Options Exercised (Deprecated 2013-01-31) USD 200,000 2013-01-01 2013-03-31 2013 Q1 10-Q 2013-05-02 0001193125-13-196184
us-gaap TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit Tax Cuts and Jobs Act, Incomplete Accounting, Provisional Income Tax Expense (Benefit) (Deprecated 2020-01-31) USD -10.50M 2018-01-01 2018-03-31 2019 FY 10-K 2020-02-28 0001564590-20-007769
us-gaap TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense Tax Cuts and Jobs Act, Incomplete Accounting, Transition Tax for Accumulated Foreign Earnings, Provisional Income Tax Expense (Deprecated 2020-01-31) USD 0 2018-01-01 2018-12-31 2019 FY 10-K 2020-02-28 0001564590-20-007769
us-gaap TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability Tax Cuts and Jobs Act, Transition Tax for Accumulated Foreign Earnings, Liability USD 0 2019-12-31 2019 FY 10-K 2020-02-28 0001564590-20-007769
us-gaap TaxesPayableCurrent Taxes Payable, Current USD 0 2023-12-31 2023 FY 10-K 2024-02-28 0000950170-24-022057
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 8.74M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2021-12-31 2021 FY 10-K 2022-03-01 0001564590-22-007930
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense USD 500,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense Unrecognized Tax Benefits, Income Tax Penalties Expense USD 48.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 7.45M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 159,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations USD 3.87M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate Unrecognized Tax Benefits that Would Impact Effective Tax Rate USD 9.00M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap VariableLeaseCost Variable Lease, Cost USD 3.88M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 0 2022-12-31 2022 FY 10-K 2023-02-28 0001564590-23-002737
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 705,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 91.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 90.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447412
us-gaap WorkersCompensationDiscountAmount Workers' Compensation Discount, Amount USD 1.86M 2012-12-31 2012 FY 10-K 2013-03-01 0001193125-13-087740
us-gaap WorkersCompensationLiabilityCurrent Workers' Compensation Liability, Current USD 18.50M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266
us-gaap WorkersCompensationLiabilityNoncurrent Workers' Compensation Liability, Noncurrent USD 15.80M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-078266

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →